Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Biliary Tract Diseases

Free Subscription Articles published in Clin Res Hepatol Gastroenterol Retrieve available abstracts of 66 articles: HTML format

Single Articles

June 2024
1. ZHAO G, Shi R, Ma M, Lin H, et al
   Elevated LDL-c may warn of the risk of gallbladder stones in the patients with metabolic dysfunction-associated steatotic liver disease: A case-control study.
   Clin Res Hepatol Gastroenterol. 2024;48:102363.
   PubMed     Abstract available
   
   
   
2. TANAKA A, Corpechot C
   PPAR agonists in PBC: Where do we go from here? Or how to choose between the new and the old.
   Clin Res Hepatol Gastroenterol. 2024;48:102358.
   PubMed     Abstract available
   
   
   May 2024
3. MARTINELLI G, Stanca S, Bosco F, Zini L, et al
   Massive lymphatic embolism in gallbladder signet ring cell carcinoma: An autopsy finding.
   Clin Res Hepatol Gastroenterol. 2024;48:102330.
   PubMed    
   
   
   
4. SALIN G, Corpechot C, Ouazana S, Dong C, et al
   Endoscopic features of low-phospholipid-associated cholelithiasis syndrome: A retrospective cohort study.
   Clin Res Hepatol Gastroenterol. 2024;48:102324.
   PubMed     Abstract available
   
   
   
5. LIANG Y, Li J, Zhang Z, Jiang T, et al
   Extrahepatic conditions of primary biliary cholangitis: A systematic review and meta-analysis of prevalence and risk.
   Clin Res Hepatol Gastroenterol. 2024;48:102321.
   PubMed     Abstract available
   
   
   April 2024
6. YUE X, Cao S, Chen Y
   Acantholytic squamous cell carcinoma of the gallbladder: Report of a rare case with diagnostic challenges.
   Clin Res Hepatol Gastroenterol. 2024;48:102316.
   PubMed    
   
   
   January 2024
7. SEXTON F, Shanahan W, Ryan JD
   Xanthoma striatum palmare: Getting a handle on hyperlipidaemia in primary biliary cholangitis.
   Clin Res Hepatol Gastroenterol. 2024;48:102255.
   PubMed    
   
   
   
8. NAYAGAM JS, Ahmed W, Farrant M, Jefferies J, et al
   Clinical factors associated with illness perception, worry and mental health in sclerosing cholangitis: A single centre prospective study.
   Clin Res Hepatol Gastroenterol. 2024;48:102251.
   PubMed     Abstract available
   
   
   December 2023
9. ZHENG L, Zhou N, Yang X, Wei Y, et al
   Clinicopathological features of a rare cancer: Intrahepatic lymphoepithelioma-like cholangiocarcinoma with Epstein-Barr virus infection.
   Clin Res Hepatol Gastroenterol. 2023;47:102244.
   PubMed     Abstract available
   
   
   
10. JANG H, Han N, Staatz CE, Kwak JH, et al
    Effect on lipid profile and clinical outcomes of obeticholic acid for the treatment of primary biliary cholangitis and metabolic dysfunction-associated steatohepatitis: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2023;47:102227.
    PubMed     Abstract available
    
    
    November 2023
11. PASCALE A, Rosmorduc O, Duclos-Vallee JC
    New epidemiologic trends in cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2023;47:102223.
    PubMed     Abstract available
    
    
    
12. MUTANEN A, Pakarinen MP
    Featuring molecular regulation of bile acid homeostasis in pediatric short bowel syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102220.
    PubMed     Abstract available
    
    
    October 2023
13. FILANOVSKY K, Temper N, Stanevsky A, Shvidel L, et al
    Vanishing bile duct syndrome in a patient with multiple myeloma treated with bortizomib, lenalidomide and dexamethasone.
    Clin Res Hepatol Gastroenterol. 2023;47:102198.
    PubMed    
    
    
    
14. DI GIORGIO A, Sciveres M, Fuoti M, Sonzogni A, et al
    Treatment with an ileal bile acid transporter inhibitor in patients with TJP2 deficiency.
    Clin Res Hepatol Gastroenterol. 2023;47:102185.
    PubMed     Abstract available
    
    
    
15. BOILLOT O, Guillaud O, Wischlen E, Ruiz M, et al
    Determinants of early surgical complications after pediatric liver transplantation: A single center/single surgeon experience over 20 years.
    Clin Res Hepatol Gastroenterol. 2023;47:102222.
    PubMed     Abstract available
    
    
    August 2023
16. VO QUANG E, Ithier G, Jager M, Plessier A, et al
    Cholangiopathy in sickle cell disease.
    Clin Res Hepatol Gastroenterol. 2023;47:102166.
    PubMed    
    
    
    May 2023
17. WISCHLEN E, Laverdure N, Erard D, Rohmer B, et al
    Iterative antibody-induced bile salt export pump deficiency after successive liver transplantations successfully treated with plasmapheresis and rituximab.
    Clin Res Hepatol Gastroenterol. 2023;47:102139.
    PubMed     Abstract available
    
    
    
18. MALKANI KV, Jesudian AB, Luo JJ, Schonfeld EA, et al
    Noncirrhotic portal hypertension in primary biliary cholangitis with coexisting CREST syndrome.
    Clin Res Hepatol Gastroenterol. 2023;47:102114.
    PubMed     Abstract available
    
    
    
19. YU AT, Khajoueinejad N, Gross A, Golas BJ, et al
    A possible role for ketorolac in the management of increased biliary drain output.
    Clin Res Hepatol Gastroenterol. 2023;47:102128.
    PubMed     Abstract available
    
    
    April 2023
20. SHIAU H, Schraw JM, Mysore K, Cavallo L, et al
    Characteristics of infections and their risk factors in children with biliary atresia.
    Clin Res Hepatol Gastroenterol. 2023;47:102109.
    PubMed     Abstract available
    
    
    
21. SASAKI M, Sato Y, Nakanuma Y
    An involvement of Hippo-yes-associated protein pathway in biliary epithelial senescence in primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2023;47:102106.
    PubMed     Abstract available
    
    
    December 2022
22. FERREIRA FB, Mourato M, Braganca S, Paulo JB, et al
    COVID-19-associated secondary sclerosing cholangitis - A case series of 4 patients.
    Clin Res Hepatol Gastroenterol. 2022;46:102048.
    PubMed     Abstract available
    
    
    
23. NEUZILLET C, Malka D, Lievre A, Khurana IS, et al
    Correlation between efficacy endpoints in patients with advanced biliary tract cancer treated by systemic second-line therapies: Analysis of aggregated data from a systematic literature review.
    Clin Res Hepatol Gastroenterol. 2022;46:102010.
    PubMed     Abstract available
    
    
    November 2022
24. WASUWANICH P, Choudry H, So JM, Lowry S, et al
    Vanishing bile duct syndrome after drug-induced liver injury.
    Clin Res Hepatol Gastroenterol. 2022;46:102015.
    PubMed     Abstract available
    
    
    
25. WU L, Yang J, Ke RS, Liu Y, et al
    Impact of lncRNA SOX9-AS1 overexpression on the prognosis and progression of intrahepatic cholangiocarcinoma.
    Clin Res Hepatol Gastroenterol. 2022;46:101999.
    PubMed     Abstract available
    
    
    October 2022
26. WANG J, Lun W, Shi W
    Effects of elevated bile acid levels on fetal myocardium in intrahepatic cholestasis of pregnancy, a retrospective study from a neonatal perspective.
    Clin Res Hepatol Gastroenterol. 2022;46:102013.
    PubMed     Abstract available
    
    
    
27. BRAN DM, Fuks D, Lansier A, Gallois C, et al
    Pathological complete response of liver metastases of cholangiocarcinoma using hepatic intra-arterial gemcitabine-oxaliplatin.
    Clin Res Hepatol Gastroenterol. 2022;46:101920.
    PubMed    
    
    
    September 2022
28. COILLY A, Sebagh M, Fougerou-Leurent C, Pageaux GP, et al
    HCV eradication does not protect from fibrosis progression in patients with fibrosing cholestatic hepatitis after liver transplantation.
    Clin Res Hepatol Gastroenterol. 2022 Sep 16:102024.
    PubMed     Abstract available
    
    
    August 2022
29. YANG SH, Hu S, Kang Q, Liu LX, et al
    EIF5A2 promotes proliferation and invasion of intrahepatic cholangiocarcinoma cells.
    Clin Res Hepatol Gastroenterol. 2022;46:101991.
    PubMed     Abstract available
    
    
    
30. JIANG H, Li W, Xue Z, Chen W, et al
    lncRNA TM4SF1-AS1 predicts dismal outcomes and promotes cholangiocarcinoma progression via modulating miR-744-3p.
    Clin Res Hepatol Gastroenterol. 2022;46:101915.
    PubMed     Abstract available
    
    
    June 2022
31. NAYAGAM JS, Mandour MO, Taylor A, Heneghan MA, et al
    Clinical course of inflammatory bowel disease and impact on liver disease outcomes in patients with autoimmune sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022 Jun 18:101980.
    PubMed     Abstract available
    
    
    April 2022
32. JAIN A, Kirkpatrick RB, Sobotka LA
    Severe pruritis during pregnancy: More than just intrahepatic cholestasis of pregnancy?
    Clin Res Hepatol Gastroenterol. 2022;46:101875.
    PubMed    
    
    
    March 2022
33. CAMPOS-PEREZ W, Perez-Robles M, Rodriguez-Echevarria R, Rivera-Valdes JJ, et al
    High dietary omega-6:omega-3 PUFA ratio and simple carbohydrates as a potential risk factors for gallstone disease: A cross-sectional study.
    Clin Res Hepatol Gastroenterol. 2022;46:101802.
    PubMed     Abstract available
    
    
    
34. ADAMS T, Liebe R, Lehmann J, Krawczyk M, et al
    Acute cholestatic liver injury following carbimazole treatment in a patient with VPS33B haploinsufficiency.
    Clin Res Hepatol Gastroenterol. 2022;46:101803.
    PubMed    
    
    
    
35. BATOOL SS, Dauer M, Weber SN, Liebe R, et al
    Intrahepatic cholestasis of pregnancy in conjunction with a frameshift deletion in FGFR4.
    Clin Res Hepatol Gastroenterol. 2022;46:101800.
    PubMed     Abstract available
    
    
    February 2022
36. JULIA S, Peter S, Karl-Heinz W, Daniel Nils G, et al
    Possible role of the HMGB1 and RAGE inflammatory pathway in primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101791.
    PubMed     Abstract available
    
    
    
37. SONG S, Yang W, Tian H, Gong S, et al
    The efficacy and safety of 5-fluorouracil based adjuvant therapy in resected biliary tract cancer: A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2022;46:101788.
    PubMed     Abstract available
    
    
    January 2022
38. NAULT JC, Blanc JF, Moga L, Calderaro J, et al
    Non-invasive diagnosis and follow-up of benign liver tumours.
    Clin Res Hepatol Gastroenterol. 2022;46:101765.
    PubMed     Abstract available
    
    
    
39. CHAZOUILLERES O, Potier P, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of primary sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101775.
    PubMed     Abstract available
    
    
    
40. CORPECHOT C, Heurgue A, Tanne F, Potier P, et al
    Non-invasive diagnosis and follow-up of primary biliary cholangitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101770.
    PubMed     Abstract available
    
    
    
41. LEMOINNE S, Heurgue A, Bouzbib C, Hanslik B, et al
    Non-invasive diagnosis and follow-up of autoimmune hepatitis.
    Clin Res Hepatol Gastroenterol. 2022;46:101772.
    PubMed     Abstract available
    
    
    November 2021
42. BOURDELEAU P, Larrey E, Allaire M, Charlotte F, et al
    "De novo" Cholangiocarcinoma 20 years after liver transplantation for primary sclerosing cholangitis: Lifelong screening needed!
    Clin Res Hepatol Gastroenterol. 2021 Nov 2:101827.
    PubMed     Abstract available
    
    
    
43. XU ZL, Ou YJ, Dai HS, Wan K, et al
    Elevated preoperative CA125 levels predicts poor prognosis of hilar cholangiocarcinoma receiving radical surgery.
    Clin Res Hepatol Gastroenterol. 2021;45:101695.
    PubMed     Abstract available
    
    
    
44. REN T, Pang L, Dai W, Wu S, et al
    Regulatory mechanisms of the bile salt export pump (BSEP/ABCB11) and its role in related diseases.
    Clin Res Hepatol Gastroenterol. 2021;45:101641.
    PubMed     Abstract available
    
    
    
45. ORLOWSKA E, Czubkowski P, Wolochowska K, Jarzebicka D, et al
    Assessment of Lactobacillus casei rhamnosus (LGG) therapy in children with biliary atresia - Randomized placebo controlled trial.
    Clin Res Hepatol Gastroenterol. 2021;45:101753.
    PubMed     Abstract available
    
    
    
46. LOPEZ DE FRUTOS L, Cebolla JJ, de Castro-Oros I, Irun P, et al
    Neonatal cholestasis and Niemann-pick type C disease: A literature review.
    Clin Res Hepatol Gastroenterol. 2021;45:101757.
    PubMed     Abstract available
    
    
    September 2021
47. NAKAMURA H, Ara M, Koga H, Miyano G, et al
    Duration from the first pale stool to portoenterostomy is prognostic in biliary atresia. Comparison with age at portoenterostomy.
    Clin Res Hepatol Gastroenterol. 2021;45:101584.
    PubMed     Abstract available
    
    
    
48. ZIMMER V
    Intraductal vacuum suction for high biliary stone retrieval during direct cholangioscopy.
    Clin Res Hepatol Gastroenterol. 2021;45:101600.
    PubMed    
    
    
    
49. BAUMANN U, Sturm E, Lacaille F, Gonzales E, et al
    Effects of odevixibat on pruritus and bile acids in children with cholestatic liver disease: Phase 2 study.
    Clin Res Hepatol Gastroenterol. 2021;45:101751.
    PubMed     Abstract available
    
    
    July 2021
50. PERRAULT F, Echelard P, Viens D, Borduas M, et al
    Contraceptive vaginal ring-induced cholestasis in a patient with a history of intrahepatic cholestasis of pregnancy.
    Clin Res Hepatol Gastroenterol. 2021;45:101475.
    PubMed     Abstract available
    
    
    May 2021
51. ZIMMER V, Reichert MC, Lammert F
    Cholesterol crystals in biliary cast syndrome related to sclerosing cholangitis in critically ill patients.
    Clin Res Hepatol Gastroenterol. 2021;45:101485.
    PubMed    
    
    
    
52. LYKAVIERIS P, Bernard O, Jacquemin E
    Ursodeoxycholic acid therapy throughout pregnancy in women affected with chronic cholestasis of childhood: No evidence for teratogenicity.
    Clin Res Hepatol Gastroenterol. 2021;45:101472.
    PubMed    
    
    
    
53. KULKARNI AV, Tevethia HV, Arab JP, Candia R, et al
    Efficacy and safety of obeticholic acid in liver disease-A systematic review and meta-analysis.
    Clin Res Hepatol Gastroenterol. 2021;45:101675.
    PubMed     Abstract available
    
    
    March 2021
54. CORPECHOT C
    The revival of preemptive UDCA therapy in liver transplant recipients: Commentary to "UDCA decreases Incidence of Primary Biliary Cholangitis and Biliary Complications after Liver Transplant: A Meta-Analysis" by Pedersen et al., Liver Transplant, Nove
    Clin Res Hepatol Gastroenterol. 2021 Mar 13:101679.
    PubMed    
    
    
    
55. FAMULARO G, Spada PL
    COVID-19-related cholecystitis.
    Clin Res Hepatol Gastroenterol. 2021;45:101635.
    PubMed    
    
    
    
56. DI GIORGIO A, Nicastro E, Arnaboldi S, Montini O, et al
    "Health status of children with chronic liver disease during the SARS-CoV-2 outbreak: results from a multicentre study".
    Clin Res Hepatol Gastroenterol. 2021;45:101610.
    PubMed    
    
    
    
57. WANG P, Tao H, Liu C, Zhou X, et al
    One-step percutaneous transhepatic cholangioscopic lithotripsy in patients with choledocholithiasis.
    Clin Res Hepatol Gastroenterol. 2021;45:101477.
    PubMed     Abstract available
    
    
    
58. YILDIRIM M, Artas H, Artas G
    False-positive PET/CT finding of hepatic inflammatory pseudotumor in IgG4-related sclerosing cholangitis.
    Clin Res Hepatol Gastroenterol. 2021;45:101645.
    PubMed    
    
    
    
59. SHEN X, Huang Y, Guo H, Peng H, et al
    Oral ibuprofen promoted cholestatic liver disease in very low birth weight infants with patent ductus arteriosus.
    Clin Res Hepatol Gastroenterol. 2021;45:101495.
    PubMed     Abstract available
    
    
    January 2021
60. LI Y, Hu M, Li L, Liu S, et al
    Successful response to monotherapy of immune checkpoint inhibitor in intrahepatic cholangiocarcinoma with high tumor mutational burden and PD-L1 expression.
    Clin Res Hepatol Gastroenterol. 2021;45:101525.
    PubMed    
    
    
    
61. KANG Y, Park S, Kim S, Han SJ, et al
    Validating the BAVENO VI criteria to identify low risk biliary atresia patients without endoscopy for esophageal varix.
    Clin Res Hepatol Gastroenterol. 2021;45:101437.
    PubMed     Abstract available
    
    
    November 2020
62. ZHAI LL, Xiang F, Wang W, Wu L, et al
    Atypical presentations of coronavirus disease 2019 in a patient with acute obstructive suppurative cholangitis.
    Clin Res Hepatol Gastroenterol. 2020;44:e135-e140.
    PubMed     Abstract available
    
    
    October 2020
63. COUCHONNAL E, Jacquemin E, Lachaux A, Ackermann O, et al
    Long-term results of pediatric liver transplantation for autoimmune liver disease.
    Clin Res Hepatol Gastroenterol. 2020 Oct 16. pii: S2210-7401(20)30275.
    PubMed     Abstract available
    
    
    
64. RAHAL HK, Tabibian JH
    The MBOAT7 rs641738 variant in primary sclerosing cholangitis: A novel biomarker for prognostication.
    Clin Res Hepatol Gastroenterol. 2020;44:619-621.
    PubMed    
    
    
    June 2019
65. RAUBER C, Awad M, Koschny R, Sauer P, et al
    Biliary calprotectin, lactoferrin and dimeric pyruvate kinase after liver transplantation are associated with biliary damage and graft survival in a case-control study.
    Clin Res Hepatol Gastroenterol. 2019 Jun 11. pii: S2210-7401(19)30102.
    PubMed     Abstract available
    
    
    
66. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Biliary Tract Diseases is free of charge.